New recombinant Factor VIII Turoctocog alfa (NovoEight®) for the Treatment and Prophylaxis of Hemophilia A approved

被引：0

作者：

Burkhardt, Dietlinde

机构：

来源：

TRANSFUSION MEDICINE AND HEMOTHERAPY | 2014年 / 41卷 / 01期

关键词：

N8; EFFICACY; SAFETY;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：92 / 93

页数：2

共 8 条

[1]

[Anonymous], 2013, FACHINFORMATION NOVO

[2] Functional characteristics of N8, a new recombinant FVIII [J].

Christiansen, M. L. S. ;

Balling, K. W. ;

Persson, E. ;

Hilden, I. ;

Bagger-Sorensen, A. ;

Sorensen, B. B. ;

Viuff, D. ;

Segel, S. ;

Klausen, N. K. ;

Ezban, M. ;

Lethagen, S. ;

Steenstrup, T. D. ;

Kjalke, M. .

HAEMOPHILIA, 2010, 16 (06) :878-887

[3] Results from a large multinational clinical trial (guardian™3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokinetics [J].

Kulkarni, R. ;

Karim, F. A. ;

Glamocanin, S. ;

Janic, D. ;

Vdovin, V. ;

Ozelo, M. ;

Rageliene, L. ;

Carboni, E. ;

Laguna, P. ;

Dobaczewski, G. ;

Seremetis, S. ;

Lindblom, A. ;

Santagostino, E. .

HAEMOPHILIA, 2013, 19 (05) :698-705

[4] Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy [J].

Lentz, S. R. ;

Misgav, M. ;

Ozelo, M. ;

Salek, S. Z. ;

Veljkovic, D. ;

Recht, M. ;

Cerqueira, M. ;

Tiede, A. ;

Brand, B. ;

Mancuso, M. E. ;

Seremetis, S. ;

Lindblom, A. ;

Martinowitz, U. .

HAEMOPHILIA, 2013, 19 (05) :691-697

[5]

Lentz SR, EXPERT OPIN ORPHAN D

[6] Bioequivalence between two serum-free recombinant factor VIII preparations (N8 and ADVATE®) - an open-label, sequential dosing pharmacokinetic study in patients with severe haemophilia A [J].

Martinowitz, U. ;

Bjerre, J. ;

Brand, B. ;

Klamroth, R. ;

Misgav, M. ;

Morfini, M. ;

Santagostino, E. ;

Tiede, A. ;

Viuff, D. .

HAEMOPHILIA, 2011, 17 (06) :854-859

[7] Guidelines for the management of hemophilia [J].

Srivastava, A. ;

Brewer, A. K. ;

Mauser-Bunschoten, E. P. ;

Key, N. S. ;

Kitchen, S. ;

Llinas, A. ;

Ludlam, C. A. ;

Mahlangu, J. N. ;

Mulder, K. ;

Poon, M. C. ;

Street, A. .

HAEMOPHILIA, 2013, 19 (01) :E1-E47

[8] International comparative field study of N8 evaluating factor VIII assay performance [J].

Viuff, D. ;

Barrowcliffe, T. W. ;

Saugstrup, T. ;

Ezban, M. ;

Lillicrap, D. .

HAEMOPHILIA, 2011, 17 (04) :695-702

← 1 →